Profound sedation, respiratory depression, coma, and death may result from the concomitant use of Buprenex with benzodiazepines or other CNS depressants (e.g., non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, other opioids, alcohol).
The MOU is developed through a process of negotiation and mutual assent, finalized through acceptance of the MOU instrument, and approved by the appropriate agency representatives who signify such approval by signing the MOU.
MEMORANDUM OF UNDERSTANDING All italicized sentences are considered instructions and should be deleted prior to the submission of the final MOU. This Memorandum of Understanding (MOU) is entered into by and between: Provide the agency name and a brief description of each agency. A. Purpose. State the purpose of the MOU.